（股份代號：2453） 自願公告 與大興發展租賃達成融資合作 本公告乃由美中嘉和醫學技術發展集團股份有限公司（「本公司」）董事會（「董事 會」）自願刊發，以知會本公司股東及潛在投資者有關本集團的最新業務發展。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致之任何損失承擔任何責任。 CONCORD HEALTHCARE GROUP CO., LTD. 美中嘉和醫學技術發展集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 通過與專業融資租賃公司合作，本公司將進一步拓展融資管道，豐富公司的資金 來源，為未來業務發展中的資金需求提供更多保障，同時也有助於公司與行業內 專業機構建立長期合作關係，為後續合作奠定基礎。 本公司股東及潛在投資者於買賣本公司股份時務請審慎行事。 承董事會命 美中嘉和醫學技術發展集團股份有限公司 董事長兼執行董事 於本公告日期，董事會包括(i)執行董事楊建宇博士、付驍女士及常亮先生；(ii)非 執行董事王雷先生、宋清寶先生及施波濤先生；及(iii) ...

Core Insights - The strategic partnership between Meizhong Jiahe Medical Technology Development Group and AIA Insurance aims to establish a cross-border cancer treatment and corporate health management ecosystem in the Guangdong-Hong Kong-Macao Greater Bay Area [1][2] - This collaboration enhances Meizhong Jiahe's high-end medical service channels and diversifies its service reach [1] - The integration of healthcare services in the Greater Bay Area presents unprecedented growth opportunities for Meizhong Jiahe [1] Group 1: Partnership and Services - AIA Insurance, with over 16 million group insurance plan members, will introduce high-quality corporate clients to Meizhong Jiahe through exclusive health benefit programs [2] - The partnership will offer a range of services including cross-border medical coordination, second medical opinions, and customized health check-ups, enriching Meizhong Jiahe's revenue streams [2] - This collaboration shifts corporate health benefits from a passive treatment model to a proactive prevention strategy, enhancing customer loyalty and lifecycle value [2] Group 2: Competitive Advantage and Market Position - Meizhong Jiahe's expertise in proton therapy, supported by top international institutions, creates a unique competitive edge [3] - The company has signaled a strategic focus on proton therapy and AI-integrated cancer treatment, positioning itself for significant industry growth [3] - The partnership with AIA Insurance is expected to stabilize patient flow, becoming a core driver of the company's performance [3] Group 3: International Expansion and Future Outlook - Meizhong Jiahe's medical services are attracting international patients from regions such as Hong Kong, Macau, Southeast Asia, and the Middle East [4] - The deepening integration of healthcare in the Greater Bay Area and improvements in cross-border payment systems will enhance the company's competitive advantage [4] - The collaboration represents a strategic alignment of scarce medical resources with insurance channels, further unlocking Meizhong Jiahe's commercial value [4]

Core Viewpoint - The strategic partnership between Meizhong Jiahe (02453) and AIA Hong Kong & Macau aims to enhance the health and wellness of employees through affordable cancer proton therapy and health check programs for eligible insured members [1] Group 1: Partnership Details - Meizhong Jiahe has announced a strategic cooperation with AIA Hong Kong & Macau [1] - The partnership allows eligible insured members of AIA Hong Kong & Macau's group insurance to access affordable cancer proton treatment and health check plans at the flagship institution "Guangzhou Taihe Cancer Hospital" [1] Group 2: Strategic Implications - This collaboration reflects AIA Hong Kong & Macau's commitment to improving overall employee health and wellness under its "AIA Friendly Workplace Life Plan" [1] - The partnership marks a significant step in Meizhong Jiahe's strategic layout in the health ecosystem, providing comprehensive and high-quality cancer and health-related services [1]

Group 1 - The core point of the article is the strategic partnership between Meizhong Jiahe (02453) and AIA Hong Kong and Macau, aimed at enhancing health services for eligible insured members [1] - Under this collaboration, eligible members of AIA's group insurance will have access to more affordable proton therapy and health check plans at the flagship institution "Guangzhou Taihe Cancer Hospital" [1] - This partnership reflects AIA Hong Kong and Macau's commitment to improving employee health and well-being through its "AIA Friendly Workplace Life Plan" [1] Group 2 - The collaboration marks a significant step in the company's strategic layout in the health ecosystem [1] - It aims to provide comprehensive and high-quality cancer and health-related services to eligible insured members of AIA Hong Kong and Macau [1]

格隆汇9月16日丨美中嘉和(02453.HK)宣布，近期公司与友邦保险(国际)有限公司的香港及澳门分行达 成战略合作。在此项合作下，友邦香港及澳门的指定团体保险的合资格受保成员，可于集团的旗舰机构 「广州泰和肿瘤医院」享有更可负担的指定癌症质子治疗及健康检查计划。此项合作体现了友邦香港及 澳门的「AIA友好职场人生计划」下致力提升雇员的整体健康福祉的策略。此项合作也标志着公司在健 康生态领域的战略布局迈出关键一步，及为友邦香港及澳门的指定团体保险的合资格受保成员带来全面 及优质的癌症和健康相关的服务。 ...

美中嘉和醫學技術發展集團股份有限公司 CONCORD HEALTHCARE GROUP CO., LTD. （於中華人民共和國註冊成立的股份有限公司） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致之任何損失承擔任何責任。 在此項合作下，友邦香港及澳門之指定團體保險的合資格受保成員，可於本集團 的旗艦機構「廣州泰和腫瘤醫院」享有更可負擔的指定癌症質子治療及健康檢查計 劃。此項合作體現了友邦香港及澳門的「AIA友好職場人生計劃」下致力提升僱員 的整體健康福祉之策略。此項合作也標誌著本公司在健康生態領域的戰略佈局邁 出關鍵一步，及為友邦香港及澳門之指定團體保險的合資格受保成員帶來全面及 優質的癌症和健康相關的服務。 本公司股東及潛在投資者於買賣本公司股份時務請審慎行事。 承董事會命 美中嘉和醫學技術發展集團股份有限公司 董事長兼執行董事 楊建宇 中國北京，2025年9月16日 於本公告日期，董事會包括(i)執行董事楊建宇博士、付驍女士及常亮先生；(ii)非 執行董事王雷先生、宋 ...

格隆汇9月16日｜友邦香港及澳门宣布与医疗集团美中嘉和(2453.HK)建立策略性合作伙伴关系。在此项 合作下，友邦指定团体保险的合资格受保成员，可于美中嘉和集团旗下的旗舰机构——广州泰和肿瘤医 院享有更可负担的指定癌症质子治疗及健康检查计划。该医院以先进的癌症治疗技术享誉业界。此项合 作体现友邦的"AIA友好职场人生计划"下致力提升雇员的整体健康福祉的策略。 ...

Core Insights - The article highlights the changes in the Hong Kong Stock Connect holdings, with notable increases and decreases in ownership percentages for various companies [1][2]. Group 1: Increased Holdings - Heng Rui Medicine (01276) saw the largest increase in ownership percentage, rising by 1.49% to a total of 13.84% [2]. - Kanglong Chemical (03759) experienced a 1.35% increase, bringing its ownership to 60.51% [2]. - Zhaoyan New Drug (06127) increased by 1.27%, reaching a holding of 43.70% [2]. - Other companies with significant increases include Junshi Biosciences (01877) at +1.24% (59.08%) and China Pacific Insurance (02601) at +1.20% (44.16%) [2]. Group 2: Decreased Holdings - Shandong Molong (00568) had the largest decrease, with a drop of 1.99% to 57.67% [2]. - Yisou Technology (02550) decreased by 0.99%, now holding 37.95% [2]. - Nanjing Panda Electronics (00553) saw a reduction of 0.98%, bringing its ownership to 42.65% [2]. - Other notable decreases include Kailai Ying (06821) at -0.95% (43.35%) and Meizhong Jiahe (02453) at -0.95% (32.06%) [2]. Group 3: Five-Day Changes - In the last five trading days, China Merchants Energy (01138) had the highest increase in ownership, up by 6.19% to 65.63% [3]. - Shandong Molong (00568) also saw a significant increase of 3.74% [3]. - Other companies with notable increases include Zhongchu Innovation (03931) at +3.62% (10.35%) and Youbao Online (02429) at +3.33% (17.38%) [3]. Group 4: Twenty-Day Changes - Over the past twenty days, Anjiren Food (02648) experienced the largest increase, up by 12.29% to 20.54% [4]. - China Merchants Energy (01138) also saw a significant increase of 9.07% [4]. - Other companies with notable increases include Yimai Sunshine (02522) at +7.70% (43.02%) and Lens Technology (06613) at +7.56% (13.64%) [4].

Core Insights - The report highlights significant changes in the Hong Kong Stock Connect holdings, with notable increases and decreases in ownership percentages for various companies [1][2]. Group 1: Companies with Increased Holdings - Shandong Molong (00568) saw the largest increase in holdings, up by 6.46%, bringing its total to 59.66% [2]. - Youbao Online (02429) experienced a 2.74% increase, resulting in a holding of 17.51% [2]. - Goldwind Technology (02208) had a 1.07% increase, with a current holding of 43.66% [2]. - Other notable increases include Ganfeng Lithium (01772) at +0.75% (35.72%), and InnoCare Pharma (01877) at +0.59% (57.84%) [2]. Group 2: Companies with Decreased Holdings - Meizhong Jiahe (02453) had the largest decrease, down by 1.55% to 33.01% [2]. - Longpan Technology (02465) decreased by 1.06%, now holding 46.05% [2]. - Kingsoft Cloud (03896) saw a reduction of 0.98%, with a current holding of 25.82% [2]. - Other significant decreases include Yisou Technology (02550) at -0.39% (38.94%) and Jiangxi Copper (00358) at -0.27% (23.65%) [3]. Group 3: Five-Day Holding Changes - Over the last five trading days, Zhongyuan Shipping (01138) had the highest increase of 7.22%, reaching 65.91% [3]. - Shandong Molong (00568) increased by 5.80% to 59.66% [3]. - Zhongchu Innovation (03931) saw a 4.08% increase, now at 9.79% [3]. - Conversely, Yisou Technology (02550) experienced the largest decrease of 8.93%, now at 38.94% [3]. Group 4: Twenty-Day Holding Changes - In the last twenty days, Anjuke Food (02648) had the highest increase of 12.30%, reaching 19.99% [4]. - Zhongyuan Shipping (01138) also saw a significant increase of 8.90%, now at 65.91% [4]. - Longpan Technology (02465) had a notable decrease of 4.92% [4].

消息面上，美中嘉和今早公布，公司获公司控股股东Concord Medical Services Holdings Limited(CCM)告 知，CCM计划于本公告起计12个月内增持公司股权。公司已获告知，为进行增持，CCM将透过其附属 公司以自有资金于公开市场进行增持，具体增持交易将根据规则及时披露。公告指，增持计划旨在巩固 CCM的控股地位，提高CCM的持股比例，并向市场传递控股股东对集团未来前景及长远发展充满信心 的积极信息。 智通财经APP获悉，美中嘉和(02453)反弹超5%，该股9月8日起正式被剔除港股通，过去四个交易日股 价累跌超三成。截至发稿，涨5.57%，报3.22港元，成交额770.41万港元。 ...